Abstract
Flavonoids, a diverse group of naturally occurring plant constituents which share the common structural feature of two phenyl rings linked by a three-carbon chain (Geissman and Hinreiner, 1952), are practically ubiquitous among vascular plants (Geissman, 1962), including food plants (Bate-Smith, 1954; Kühnau, 1976). The three-carbon chain may be formed into a third six-membered ring through an oxygen on one of these phenyl rings, and the naturally occurring derivatives are frequently polyphenolic. The structure and numbering of some common naturally-occurring flavonoids are illustrated in Figure 1.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aeschbacher, H-U., Meier, H. and Ruch, E. (1982). Nonmutagenicity in vivo of the food flavonol quercetin. Nutrition and Cancer 4, 90–98.
Amacher, D.E., Paillet, S. and Ray, V.A. (1979). Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells, I. Application to genetic toxicology testing. Mutat. Res. 64, 391–406.
Ambrose, A.M., Robbins, D.J., and Deeds, F. (1952). Comparative toxicities of quercetin and quercitrin. J. Am. Pharm. Assoc. 41, 119–122.
Axelrod, J. and Tomchick, R. (1959). Activation and inhibition of adrenaline metabolism. Nature (Lond.) 184, 2027.
Bate-Smith, E.C. (1954). Flavonoid compounds in foods. Adv. Food. Res. 5, 261–300.
Belt, J.A., Thomas, J.A., Buchsbaum, R.N. and Racker, E. (1979). Inhibition of lactate transport and glycolysis in Erlich ascites tumor cells by bioflavonoids. Biochemistry 18, 3506–3511.
Bjeldanes, L.F. and Chang, 6.W. (1977). Mutagenic activity of quercetin and related compounds. Science 197, 577–578.
Brown, J.P. (1980). A review of the genetic effects of naturally occurring flavonoids, anthraquinones and related compounds. Mutat. Res. 75, 243–277.
Brown, J.P. and Dietrich, P.S. (1979). Mutagenicity of plant flavonols in the Salmonella/mammalian microsome test-Activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. Mutat Res. 66, 223–240.
Buening, M.K., Chang, R.L., Huang, M-T., Fortner, J.G., Wood, A.W. and Conney, A.H. (1981). Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res. 41, 67–72.
Carrano, A.V. and Thompson, L.H. (1982). Sister chromatid exchange and single gene mutation. Cytogenet. Cell Genet. 33, 57–61.
Carver, J.H., Carrano, A.V. and Macgregor, J.T. (1983). Genetic effects of the flavonols galangin, kaempferol, and quercetin on Chinese hamster ovary cells in vitro. Mutat. Res. 113. 45–60.
Conney, A.H. (1982). Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res. 42, 4875–4917.
Cea, G.F.A., Etcheberry, K.F.C. and Dulout, F.N. (1983). Induction of micronuclei in mouse bone marrow by the flavonoid 5,31,41-trihydroxy-3,6,7,8-tetramethoxyflavone (THTMF). Mutat. Res. 119, 339–342.
Clark, W.G. and Geissman, T.A. (1949). Potentiation of effects of epinephrine by flavonoid (“vitamin P-like”) compounds. Relation of structure to activity. J. Pharmacol. Exp.Ther. 95, 363–381.
Clemetson, C.A.B, and Anderson, L. (1966). Plant polyphenolics as antioxidants for ascorbic acid. Ann. N.Y. Acad. Sci. 136339–378.
Deeds, F. (1968). Flavonoid metabolism, inComprehensive Biochemistry, Vol. 20, ed. M. Florkin and E.H. Stotz, Elsevier, Amsterdam, pp. 127–171.
Detty, W.E., Heston, B.O. and Wender, S.H. (1955). Amperometric titrations of some flavonoid compounds with cupric sulfate. 3. Am. Chem. Soc. 77162–165.
Elliger, C.A., Henika, P.R. and Macgregor, J.T. (In press). Mutagenicity of flavones, chromones and acetophenones in Salmonella typhimurium: New structure-activity relationships. Mutat. Res. 00, 000–000.
Erturk, E., Nunoya, T., Hatcher, J.F., Pamukcu, A.M. and Bryan, G.T. (1983). Comparison of bracken fern and quercetin carcinogenicity in rats. Proc. Seventy-Fourth Ann. Mtg. Am. Assoc. Cancer Res. 24, 53 (March, 1983 ).
Fiebrich, F. and Koch, H. (1979). Silymarin, an inhibitor of lipoxygenase. Experientia 35, 1548–1550.
Fiebrich, F. and Koch, H. (1979). Silymarin, an inhibitor of prostaglandin synthetase. Experientia 35. 1550–1552.
Geissman, T.A. and Hinreiner, E. (1952). Theories of the biogenesis of flavonoid compounds. Bot. Rev. 18, 77 - 244.
Geissman, T.A. (1962). The Chemistry of Flavonoid Compounds, MacMillan, New York.
Graziani, Y. (1977). Bioflavonoid regulation of ATPase and hexokinase activity in Erlich ascites cell mitochondria. Biochim. Biophys. Acta. 460, 364–373.
Graziani, Y. and Chayoth, R. (1979). Regulation of cyclic AMP level and synthesis of DNA, RNA and protein by quercetin in Erlich ascites tumor cells. Biochem. Pharmacol. 28, 397–403.
Graziani, Y., Chayoth, R., Karny, N., Feldman, B. and Levy, J. (1982). Regulation of protein kinases activity by quercetin in Erlich ascites tumor cells. Biochim. Biophys. Acta. 714415–421.
Graziani, Y., Winikoff, J. and Chayoth, R. (1977). Regulation of cyclic AMP level and lactic acid production in Erlich ascites tumor cells. Biochim. Biophys. Acta 497, 499–506.
Griffiths, L.A. (1975). The role of the intestinal microflora in flavonoid metabolism, in Flavonoid Chem. Biochem.. Proc. 4th Hung. Bioflavonoid Symp., Elsevier, Amsterdam, pp. 201–213.
Griffiths, L.A. (1982). Mammalian metabolism of flavonoids, in The Flavonoids: Advances in Research, ed. J.B. Harborne and T.J. Mabry, Chapman and Hall, Lond., pp. 681–718.
Gugler, R., Leschik, M. and Dengler, H.J. (1975). Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 9, 229–234.
Hardigree, A.A. and Epler, J.L. (1977). Mutagenicity of plant flavonols in microbial systems. Abstr. 8th Ann. Htg. Environmental Mutagen Society, Colorado Springs, Colorado, p. 48.
Hardigree, A.A. and Epler, J.L. (1978). Comparative mutagenesis of plant flavonoids in microbial systems. Mutat. Res. 58, 231–239.
Hirono, I., Ueno, I., Hosaka, S., Takanashi, H., Matsushima, T., Sugimura, T. and Natori, S. (1981). Carcinogenicity examination of quercetin and rutin in ACI rats. Cancer Lett. 11. 15–21.
Hirose, M., Fukushima, S., Sakata, T., Inui, M. and Ito, N. (1983). Effect of quercetin on two-stage carcinogenesis of the rat urinary bladder. Cancer Lett. 21, 23–27.
Horowitz, R.M. (1981). Flavonoids, mutagens, and citrus, in Quality of Selected Fruits and Vegetables of North America, ed. R. Teranishi and H. Barrera-Benitez, American Chemical Society, Washington, D.C., pp. 43–59.
Hosaka, S. and Hirono, I. (1981). Carcinogenicity test of quercetin by pulmonary adenoma bioassay in strain A mice. Gann 72, 327–328.
Hozier, J., Sawyer, J., Moore, M., Howard, B. and Clive, D. (1981). Cytogenetic analysis of the L5178Y/TK TlC mouse lymphoma mutagenesis assay system. Mutat. Res. 84, 169–181.
Ishitsuka, H., Ohsawa, C., Ohiwa, T., Umeda, I. and Suhara, Y. (1982). Antipicornavirus flavone Ro 09-0179. Antimicrob. Ag. Chemother. 22, 611–616.
Kato, R., Nakadate, T., Yamamoto, S. and Sugimura, T. (1983). Inhibition of T2-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 4, 1301–1305.
K’uhnau, J. (1976). The flavonoids. A class of semi-essential food components: Their role in human nutrition. Wld. Rev. Nutr. Diet. 24, 117–191.
Lang, D.R. and Racker, E. (1974). Effects of quercetin and Fx inhibitor on mitochondrial ATPase and energy-linked reactions in submitochondrial particles. Biochim. Biophys. Acta 333, 180–186.
Lee, T-P., Matteliano, M.L. and Middleton, E., Jr. (1982). Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism. Life Sci. 31. 2765–2774.
Macgregor, J.T. and Jurd, L. (1978). Mutagenicity of plant flavonoids: Structural requirements for mutagenic activity in Salmonella typhimuri um. Mutat. Res. 54, 297–309.
Macgregor, J.T., Wehr, C.M., Manners, G.D., Jurd, L., Minkler, J.L. and Carrano, A.V. (1983). In vivo exposure to plant flavonols: Influence on frequencies of micronuclei in mouse erythrocytes and sister-chromatid exchange in rabbit lymphocytes. Mutat. Res. 124, 255–270.
Martin, G.J., Graff, M., Brendel, R. and Beiler, J.M. (1949). Effect of vitamin P compounds on the action of histidine decarboxylase. Arch. Biochem. 21, 177–180.
Martin, G.J., Szent-Györgyi, A., et aK (1955). Bioflavonoids and the capillary. Ann. N.Y. Acad. Sci. 61, 637–736.
Maruta, A., Enaka, K. and Umeda, H. (1979). Mutagenicity of quercetin and kaempferol on cultured mammalian cells. Gann 70, 273–276.
Mazaki, M., Ishii, T. and Uyeta, M. (1982). Mutagenicity of hydrolysates of citrus fruit juices. Mutat. Res. 101283–291.
Mccann, J. and Ames, B.N. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion. Proc. Nat. Acad. Sci. USA 73, 950–954.
Mccann, J., Choi, E., Yamasaki, E. and Ames, B.N. (1975). Detection of carcinogens as mutagens in the Salmonella/ microsome test: Assay of 300 chemicals. Proc. Nat. Acad. Sci. USA 72, 5135–5139.
Meltz, M.L. and Macgregor, J.T. (1981). Activity of the plant flavonol quercetin in the mouse lymphoma L5178Y TK mutation, DNA single-strand break and BALB/c 3T3 chemical transformation assays. Mutat. Res. 88, 317–324.
Middleton, E., Jr. and Drzewiecki, G. (1982). Effects of flavonoids and transitional metal cations on antigen-induced histamine release from human basophils. Biochem. Pharmacol. 31, 1449–1453.
Middleton, E., Jr., Drzewiecki, G. and Krishnarao, D. (1981). Quercetin: An inhibitor of antigen-induced human basophil histamine release. J. Immunol. 127, 546–550.
Morino, K., Matsukura, N., Kawachi, T., Ohgaki, H., Sugimura, T. and Hirono, I. (1982). Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration. Carcinogenesis 3, 93–97.
Nagao, M., Morita, N., Yahagi, T., Shimizu, M., Kuroyanagi, M., Fukuoka, M., Yoshihira, K., Natori, S., Fujino, T. and Sugimura, T. (1981). Mutagenicities of 61 flavonoids and 11 related compounds. Environ. Mutagenesis 3, 401–419.
Pamukcu, A.M., Yalciner, S., Hatcher, J.F. and Bryan, G.T. (1980). Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res. 40, 3468–3472.
Perry, K.L. and Walker, G.C. (1982). Identification of plasmid (pKM101)-coded proteins involved in mutagenesis and UV resistance. Nature (Lond.) 300, 278–281.
Perry, P. and Evans, H.J. (1975). Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature (Lond.) 258, 121–125.
Podhajcer, O.L., Friedlander, M. and Graziani,Y. (1980). Effect of liposome-encapsulated quercetin on DNA synthesis, lactate production, and cyclic adenosine 31:5’-monophosphate level in Erlich ascites tumor cells. Cancer Res. 40, 1344–1350.
Popova, T.P., Litvinenko, V. L. and Kovalev, I.P. (1973). Flavones of Scutellaria baicalensis roots. Khim. Prir. Soedin 6, 729–733.
Popova, T.P., Litvinenko, V. L. and Pakaln, D.A. (1979). Study of phenol compounds of populations of Scutellaria sevanensis, Farm Zh. (Kiev) 6, 49–53.
Richardson, G.A., El-Rafey, M.S. and Long, M.L. (1947). Flavones and flavone derivatives as antioxidants. J. Dairy Sci. 30, 397–413.
Sacks, L.E. and Macgregor, J.T. (1982). The B. subtil is multigene sporulation test for mutagens: Detection of mutagens inactive in the Salmonella his reversion test. Hutat. Res. 95, 191–202.
Sacks, L.E. and Macgregor, J.T. (In press). The Bacillus subtilis multigene sporulation test for detection of environmental mutagens, in Chemical Mutagens, Vol. 9, ed. F.J. deSerres, Plenum Press, p. 000-000.
Sahu, R.K., Basu, R. and Sharma, A. (1981). Genetic toxicological testing of some plant flavonoids by the micronucleus test. Mutat. Res. 89, 69–74.
Saito, D., Shirai, A., Matsushima, T., Sugimura, T., and Hirono, I. (1980). Test of carcinogenicity of quercetin, a widely distributed mutagen in food. Teratogen. Carcinogen. Mutagen. 1, 213–221.
Savage, P.C. (1977). Microbial ecology of the gastrointestinal tract. Ann. Rev. Microbiol. 31, 107–133.
Scarborough, H. and Bacharach, A.L. (1949). Vitamin P. Vitamins and Hormones 7, 1–55.
Scheline, R.R. (1978). Mammalian Metabolism of Plant XenobioticsAcademic Press, N.Y., pp. 295–329.
Schwartz, A. Sutton, S.L. and Middleton, E., Jr. (1982). Quercetin inhibition of the induction and function of cytotoxic T lymphocytes. Immunopharmacol. 4, 125–138.
Simpson, T.H. and Uri, N. (1956). Hydroxyflavones as inhibitors of the aerobic oxidation of unsaturated fatty acids. Chemistry and Industry. 956–957.
Spector, M., O’Neal, S. and Racker, E. (1980). Reconstitution of the Na+K+ pump of Erlich ascites tumor and enhancement of efficiency by quercetin. J. Biol. Chem. 255, 5504–5507.
Suolinna, E-M., Buchsbaum, R.N. and Racker, E. (1975). The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res. 35, 1865–1872.
Suolinna, E-M., Lang, D. and Racker, E. (1974). Quercetin, an artificial regulator of the high aerobic glycolysis of tumor cells. J. Natl. Cancer Inst. 53, 1515–1519.
Sugimura, T., Nagao, M., Matsushima, T., Yahagi, T., Scino, Y., Shirai, A., Sawamura, M., Natori, S., Yoshihira, K., Fukuoka, M. and Kuroyanagi, M. (1977). Mutagenicity of flavone derivatives. Proc. Jpn. Acad.. Ser. B. 53, 194–197.
Takanashi, H., Aiso, S. and Hirono, I. (1983). Carcinogenicity test of quercetin and kaempferol in rats by oral administration. J. Food Safety 5, 55–60.
Ueno. I., Nakano, N. and Hirono, I. (1983). Metabolic fate of [ C] quercetin in the ACI rat. Japan. J. Exp. Med. 53, 41–50.
Umezawa, K., Matsushima, T., Sugimura, T., Hirakawa, T., Tanaka, M., Katoh, Y., and Takayama, S. (1977). In vitrotransformation of hamster embryo cells by quercetin. Toxicol. Lett. 1, 175–178.
United States Department of Health and Human Services (1983). Fiscal Year 1983 Annual Plan. National Toxicology Program. Research Triangle Park, N.C.
van der Hoeven, J.C.M., Bruggeman, I.M. and Debets, F.M.H. (In press). Genotoxicity of quercetin in cultured mammalian cells. Mutat. Res. 000. 000–000.
Varma, S.D. and Kinoshita, J.H. (1976). Inhibition of lens aldose reductase by flavonoids - Their possible role in the prevention of diabetic cataracts. Biochem. Pharmacol. 25., 2505–2513.
Vogel, E. (1975). Some aspects of the detection of potential mutagenic agents in Drosophila. Mutat. Res. 29, 241–250.
Wargovich, M.J. and Newmark, H.L. (1983). Inability of several mutagen-blocking agents to inhibit 1, 2-dimethylhydrazine-induced DNA-damaging activity in colonic epithelium. Mutat. Res. 121, 77–80.
Watson, W.A.F. (1982). The mutagenic activity of quercetin and kaempferol in Drosophila melanogaster. Mutat. Res. 103, 145–147.
Wattenberg, L.W. and Leong, J.L. (1968). Inhibition of the carcinogenic action of 7,12-dimethylbenz(a)anthracene by beta-naphthoflavone. Proc. Soc. Exp. Biol. Med. 128, 940–943.
Wattenberg, L.W. and Leong, J.L. (1970). Inhibition of the carcinogenic action of benzo(a)pyrene by flavones. Cancer Res. 30, 1922–1925.
Wattenberg, L.W., Page, M.A. and Leong, S.L. (1968). Induction of increased benzpyrene hydroxylase activity by flavone and related compounds. Cancer Res. 28, 934–937.
Wollenweber, E. and Dietz, V.H. (1981). Occurrence and distribution of free flavonoid aglycones in plants. Phytochem. 20, 869–932.
Yoshida, M.A., Sasaki, M., Sugimura, K., and Kawachi, T. (1980). Cytogenetic effects of quercetin on cultured mammalian cells. Proc. Japan Acad. 56(B), 443–447.
Zaprometov, M.N. (1959). Vitamin P and its uses, in Vitamin P, Its Properties and Uses, Akademiya Nauk SSSR, Vitamin Sources and their Utilization, Collection 4, Trans, for Nat. Sci. Found., Washington, D.C. by Israel Program for Scientific Translations, Jerusalem, 1963, pp. 3–21.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
MacGregor, J.T. (1984). Genetic and Carcinogenic Effects of Plant Flavonoids: An Overview. In: Friedman, M. (eds) Nutritional and Toxicological Aspects of Food Safety. Advances in Experimental Medicine and Biology, vol 177. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4790-3_23
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4790-3_23
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4792-7
Online ISBN: 978-1-4684-4790-3
eBook Packages: Springer Book Archive